Today's Liberal News

This Week in Statehouse Action: Take Me Out edition

Toodles, March. In like a lion, out like … well, it’s out.

You know what GOP state lawmakers very much do not want out?

Any LGBTQ Americans.

As ever, Republicans are scratching away at voting rights and public education and abortion access and … well, anything their grubby little fingers can scrawl a grubby little bill to address.

Penguin Random House announces ‘The Climate Book,’ compiled by Greta Thunberg

Greta Thunberg is already a published author, having co-written the family memoir Scenes from the Heart and released the collection of speeches No One is Too Small to Make a Difference, along with being the subject of the biography Our House is on Fire. Now, she’s curating the handbook on climate change. The 19-year-old has compiled essays and advice from a host of luminaries for the forthcoming The Climate Book, to be published in the U.K.

‘Prestige doesn’t pay the bills,’ unionizing Condé Nast workers say, this week in the war on workers

Four of Condé Nast’s publications—Ars Technica, Pitchfork, Wired, and The New Yorker—have already unionized. But this week brought big news, in the form of a companywide union at the publishing giant’s other brands. That’s more than 500 workers, which is very small compared to the Amazon warehouse that unionized this week, but very big compared to, say, a Starbucks store.

The SAT Isn’t What’s Unfair

Critics of standardized tests have had plenty of reasons to celebrate lately. More than three-quarters of colleges are not requiring the SAT or the ACT for admission this fall, an all-time high, and more than 400 Ph.D. programs have dropped the GRE, up from a mere handful a few years ago. MIT’s announcement on Monday that it is reinstating a testing requirement for fall 2023 admissions was a major departure from these recent trends.

The “Putin Is Bad, But” Republicans

On Thursday, in a dim conference room in the bowels of a Washington, D.C., hotel, about 150 conservatives gathered for a day of group therapy. They had all been traumatized by the Russian invasion of Ukraine, which had left them questioning their assumptions about the world. But Vladimir Putin’s war of aggression wasn’t what confounded them most; for these conservatives, a mix of D.C.

Why The Dropout Succeeds Where Other Scammer Shows Fall Short

A familiar voice opens the latest episode of The Dropout, Hulu’s series about the fall of the infamous blood-testing start-up Theranos: “You founded this company 12 years ago, right? Tell them how old you were.” It’s former President Bill Clinton, praising the company founder and figurehead, Elizabeth Holmes, as played by Amanda Seyfried. “I was 19,” Seyfried replies in Holmes’s near-parodic baritone, to a wave of admiring laughter and applause.

Calls Grow for Medicare for All; Uninsured & Communities of Color Hurt Most by End of COVID-19 Funds

With COVID-19 coverage ending for the uninsured, we look at how uninsured people and communities of color will bear the impact of the end to free COVID-19 testing, treatment and vaccines, and how the pandemic has led to a renewed push for Medicare for All. We are joined by Dr. Oni Blackstock, primary care and HIV physician and founder and executive director of Health Justice, and Dr.

GOP states move from banning surgical abortions to focusing on the pill, too

Almost five decades after the landmark decision of Roe v. Wade legalized abortion nationwide, abortion rights are at great risk. Across the country, Republican-majority states are introducing bills to ban abortion at a rapid rate. At least 15 GOP-controlled states have introduced bills that ban abortion despite circumstances of incest or rape, with some proposed bans beginning as early as 30 days after conception.

Ivermectin doesn’t work as a COVID-19 treatment, but the believers aren’t going to stop believing

A large study confirms it: Ivermectin is not an effective treatment for COVID-19. If you have parasites, the drug might be a good choice—follow your doctor’s advice on that. But a double-blinded study of 1,300 patients in Brazil, half of whom got ivermectin and half of whom got a placebo, found no benefit from the drug.

Ivermectin does not reduce the risk of hospitalization from COVID-19, the study found.